Abiopharma

News list

Shaw Shannon 🟢 acquired 16.2K shares (1 derivative) of Angi Inc. (ANGI) Transaction Date: Mar 26, 2026 | Filing ID: 000030

Full text

News bot March 30, 2026, 11:40 p.m.
🔍 Shaw Shannon (Executive)

Company: Angi Inc. (ANGI)

Report Date: 2026-03-26
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 16,250
Detailed Transactions and Holdings:
- Acquired 16,250 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,250.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.
- F2: The restricted stock units vest in one installment on March 1, 2027, subject to the Reporting Person's continued service to the Issuer on the vesting date.